AKT mediates the pro-survival effects of KIT in ovarian cancer cells and is a determinant of sensitivity to imatinib mesylate (Q60448478)
Jump to navigation
Jump to search
scientific article published on 12 December 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AKT mediates the pro-survival effects of KIT in ovarian cancer cells and is a determinant of sensitivity to imatinib mesylate |
scientific article published on 12 December 2006 |
Statements
AKT mediates the pro-survival effects of KIT in ovarian cancer cells and is a determinant of sensitivity to imatinib mesylate (English)
Barbara C Vanderhyden
12 December 2006
1 reference